fbpx

TRANSCRIPT: PSA National President opening address at PSA24

2 August 2024

 

Thank you, Aunty Joan Bell, for the beautiful and warm Welcome to Country and for sharing her story with us.

 

I too, would like to acknowledge the traditional custodians of the land we meet on today, the Gadigal People of the Eora Nation.

 

In the spirit of reconciliation, PSA acknowledges the Traditional Custodians of Country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present. I personally extend that respect to all Aboriginal and Torres Strait Islander peoples today.

 

Good morning PSA.

 

In preparing today’s opening, I reflected on our journey in the past 2 years.

 

Two years ago, I delivered my first opening plenary at PSA22– I was exhilarated, nervous, but motivated.

 

This time last year, as I delivered my second opening plenary – I, together with the profession that I love dearly, we were solemn. I would say melancholy at times, but we were cautiously hopeful. We were hopeful because of our belief in our profession, in our community we serve, in our resilience, in our impact and our irreplaceable role.

 

Today 12 months later, I stand here, together with you PSA members, my Board, Branch Presidents, Branch Committees and the amazing PSA Team, and the 3 words I’ve chosen are optimistic, assured, and focused.

 

On behalf of our profession, I am grateful to our government. I want to acknowledge and thank our Federal Minister for Health and Aged Care Minister Mark Butler who will be joining us this afternoon, and Assistant Minister Emma McBride, who is present with us today.

 

After 15 months of uncertainty, our profession welcomed the signing of the 8th Community Pharmacy Agreement and Strategic Agreement. I want to acknowledge the work of the Pharmacy Guild of Australia, their National President Prof Trent Twomey and his team, some of them are with us today. The 8CPA has delivered the much-needed certainty our community pharmacy sector needed.

 

Also on behalf of the profession, I am incredible proud of PSA’s achievement and signing of the first, historic, Strategic Agreement on Pharmacist Professional Practice is monumental.

 

For the first time, the Strategic Agreement articulates the Australian Government’s commitment to support the highest standard of professionalism in pharmacy. Through this Agreement, for the very first time our profession as a whole, received formal recognition and support for our professional practice – recognising that we are an essential part of the healthcare team, and importantly the respect that pharmacists deserve as clinicians in this health care system.

 

For the first time, there is shared vision between our profession and the Commonwealth Government to continue to expand the range of primary healthcare services pharmacists provide, regardless of areas of practice.

 

The Strategic Agreement gives recognition to pharmacists’ expertise and contribution to quality use of medicines and medicine safety.

 

It gives confidence to our patients, our funders and our health system. It gives our profession the framework for standards and guidelines moving forward, as we continue to navigate through practice and health landscape changes.

 

Whilst these are all positive news, as I mentioned earlier, we need to remain focused. The work is not done. Whilst there is ongoing funding for HMRs and RMMRs, and that the Aged Care On-site Pharmacist Program has now formally commenced, the work and viability of our credentialed pharmacist workforce will not be forgotten.

 

Regardless of areas of practice, I truly have never felt so positive about the opportunity for pharmacists to reach our full potential. These opportunities are driven by real needs of our patients and our health system.

 

The current Scope of Practice Review is our opportunity – it is what I would describe as a once-in-a-career lifetime opportunity to challenge the very foundation of health system administration – to achieve equity for all health professionals, including pharmacists, in terms of regulations, funding policy and workforce development. Whether it is through our submissions, in formally representing pharmacists on the Expert Advisory Committee, in attending workshops – members can be assured that PSA is making strong representation.

 

What we want to see is:

 

Removing of unnecessary red tapes, empowering pharmacists to achieve our full and top of scope in being stewards of medicines safety, to have responsibility for the outcomes of and accountability for the outcomes of medicine use, and to truly be the first port of call for primary healthcare.

 

Through national harmonisation of states and territories legislation and regulations – patients across the country should be able to access the same level of healthcare access, not just in those areas where their postcodes are in the 4000’s.

 

Direct referral to pathology – if you’re undertaking a medication review, you should be able to order and access pathology tests which are critical to making meaningful recommendations, consistent with treatment guidelines.

 

Whether you are prescribing or undertaking medication management reviews, it makes no sense you can’t send a patient for Medicare funded blood tests relevant to that service. And it certainly does not make sense that you can’t contribute clinical notes to a patient’s health record.

 

There should be consistent funding policies – We should have access to the MBS for consultation, and should be able to prescribe medicines within our scope under the PBS.

 

Same job same pay – We should get paid the same for providing a vaccination as any other immunisers.

 

Our workforce should be supported to be integrated within multidisciplinary care teams in a meaningful way – in terms of roles, recognition and remuneration.

 

We can do more, but we must also be supported and remunerated to do more. We cannot keep adding more work, we cannot keep expecting pharmacists to do more with less.

 

We need technology to be a facilitator, not a barrier.

 

We need the teams around us to take on more technical work so that we can focus on more cognitive work.

 

We need regulation that is up to date, that supports safer, more efficient care, not get in the way of it.

 

We need to spend more time using the full extent of our skills and expertise to provide patient care.

 

These are sensible and very long overdue asks. Once the report is finalised, we urge the government to start implementing the Review’s recommendations immediately.

 

Executed well, this will dramatically simplify our unnecessarily complicated health system and help all health professionals, including pharmacists, increase their capacity to provide care.

 

I want to take this opportunity to thank and acknowledge representatives from the Department of Health and Aged Care for their work, and PSA appreciates your work and we look forward to continuing our collaborative effort to achieve this aim.

 

Australians deserve a health system which functions better than it does now.

 

This afternoon, I hope you will join me in attending Minister Mark Butler’s address.

 

Today Minister Butler will officially launch our vision for the future of pharmacy practice in Australia – Pharmacists in 2030.

 

Pharmacists in 2030 leverages the real appetite for change in our health system, driven by patient needs, and importantly provides a roadmap for the next 6 years on how pharmacists’ full potential can be realised.

 

It helps government, policymakers and funders understand our value and potential.

 

While I won’t spoil its contents, I will say a huge thank you to every one of you, our members, our elected officials, PSA Team, the Australian Pharmacy Leaders Forum member organisations who are also here today, and our consumers, who contributed to this document.

 

Martin Luther King Jr once said: “The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and controversy.”

 

Pharmacists – We know it hasn’t been easy. We know practice is getting harder and more complex. We know it can be overwhelming. But, we must keep going.

 

As we continue to evolve our profession to meet healthcare needs of Australians, I see the next 5 years as critical in the development and preparation of our workforce.

 

PSA’s work will focus on building a pharmacy workforce which has the capability and capacity to meet the health needs of Australians into the future.

 

No matter what, PSA is pharmacy, and PSA is here throughout our pharmacy career, and we should never feel alone. We are here, we are all here to be your career partner to navigate the future together.

 

It is now time to welcome our Assistant Minister for Mental Health and Suicide Prevention, and Assistant Minister for Rural and Regional Health, Emma McBride, to the stage.

 

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacy Student of the Year finalists head to PSA24

5 July 2024

 

 

The Pharmaceutical Society of Australia (PSA) has today announced the finalists for its annual Pharmacy Student of the Year competition who will compete for the top prize at PSA’s national conference PSA24 in August.

 

The final will test pharmacy students with a real-life clinical situation, where a patient will present with symptoms or a specific medicine or product request. Students are then required to use their clinical knowledge and communication skills to identify the most appropriate management, tailoring their response to provide the patient-centred advice.

 

A judging panel will assess all state finalists before selecting the national winner to be announced at PSA24’s Gala Dinner.

 

The 2024 PSA Viatris Pharmacy Student of the Year finalists are:

  • Blake Fraser, University of Technology Sydney (NSW finalist)
  • Emily Schrek, La Trobe University (Victorian finalist)
  • Bridget Cleary, University of Western Australia (WA finalist)
  • Tobey Adubasim, University of Tasmania (Tasmanian finalist)
  • Hayden Scott, University of Canberra (ACT finalist)
  • Shylee-Jade Hadar-Pagliari, James Cook University (Queensland finalist)
  • Callum Gunn, University of South Australia (SA finalist)
  • Lauren Murray, Charles Darwin University (NT finalist)
  • McKinley Nolan, University of Tasmania (NAPSA Wildcard finalist)

 

PSA National President Associate Professor Fei Sim FPS congratulated the PSOTY competition finalists.

 

“The Pharmacy Student of the Year competition showcases the talents of the next generation of pharmacists, giving them the opportunity to develop and grow their skills,” Associate Professor Sim said.

 

“It’s exciting to see such enthusiastic students entering our profession and dedicating their futures to improving the health and wellbeing of our communities.

 

“Award sponsor Viatris and PSA are proud to sponsor the finalists to attend the PSA24 conference where they will compete in the national finals.

 

“Congratulations to all the students who’ve participated in the competition this year for their dedication and commitment to pharmacy. Regardless of the outcome, you are already winners and should feel very proud for putting yourselves out of your comfort zone, for stepping up and taking on the challenge. This is exactly the ethos of our profession.”

 

PSA extends thanks to the PSOTY award sponsor, Viatris, for their ongoing support and wishes all finalists the best of luck at the national final.

 

Find out more about the PSA Pharmacy Student of the Year competition by visiting www.psa.org.au/psoty 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA partner in PRIDE project, supporting safe and inclusive care for LGBTQIA+ Australians

28 June 2024

 

The Pharmaceutical Society of Australia (PSA) is proudly partnering with the University of Queensland (UQ) to foster inclusive and empowered primary care workforces through the Promoting queer-inclusive professional identities for diversity in primary healthcare (PRIDE co-design) project.

 

Funded through the Medical Research Future Fund (MRFF), the PRIDE project aims to make affirming care more accessible through a national network of empowered LGBTQIA+ practitioners and allies, building capacity of the mainstream primary care sector to address the health needs of the LGBTQIA+ community in a safe and inclusive way.

 

The project will work with a range of peak professional bodies to deliver tailored education to health professionals. As a PRIDE project partner, PSA will offer education and resources to help pharmacists improve the care they provide LGBTQIA+ patients, starting with a session at PSA’s national conference in August.

 

PSA National President Associate Professor Fei Sim FPS said there is still a long way to go to addressing health inequalities for LGBTQIA+ Australians.

 

“Everyone has the right to safe, affirming health care,” Associate Professor Sim said.

 

57% of LGBTQIA+ Australians have reported discrimination due to their sexual orientation, and almost 80% of people who are trans or gender diverse had experienced discrimination due to their gender identity. Stigma and discrimination in the health care context contributes to greater health disparities experienced by LGBTQIA+ communities and can lead to delaying or avoiding healthcare entirely.

 

“As some of the most accessible health care professionals, pharmacists have a duty of care to patients to ensure that healthcare is provided in a way that is inclusive and appropriate for all people.

 

“PSA strongly believes in the potential of PRIDE co-design project to have a transformative impact on the development of inclusive and affirming models of care for LGBTQIA+ people experiencing intersectional disadvantage within our health care system.

 

“We are proud to be working with Dr Ross and her team to provide pharmacists with the resources and training needed to promote truly person-centred care,” A/Prof Sim concluded.

 

PRIDE Project leader and Chief Investigator Dr Megan Ross highlighted the importance of creating a culture of safe and supportive environments for LGBTQIA+ health practitioners, too.

 

“Building the capacity of the primary health workforce to deliver safe and affirming care has to include creating safe and inclusive environments for health providers. Too often we see trans and queer practitioners exit the workforce, we need a culture of inclusion that supports LGBTQIA+ practitioners to remain in the workforce and provide safe and affirming care to the community,” Dr Ross said.

 

“Building multi-disciplinary, connected and trusted network of safe and affirming providers addresses a current gap in primary care.

“A multi-disciplinary affirming provider network will facilitate access to continuous, trustable safe and affirming care across the primary care landscape for LGBTQIA+ consumers, and support LGBTQIA+ practitioners to feel safe and supported in their workplaces.”

 

Delegates attending PSA24 will have the opportunity to connect with the PRIDE Project during the session Does the pharmacy profession get a rainbow tick? presented by Professor Lisa Nissen and Dr Jean Spinks on Sunday 4 August, 2024.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA Faye McMillan Conference Grant launched for its second year

22 March 2024

 

“Creating spaces of belonging is a critical component for reconciliation in this country. Grant opportunities such as this allow us to hold this space for others to come into.”

Faye McMillan

The Pharmaceutical Society of Australia (PSA) is proud to launch the PSA Faye McMillan Conference Grant for the second consecutive year, with support from Care Pharmaceuticals and Hydralyte.

Aboriginal & Torres Strait Islander pharmacists and interns are invited to apply for the Conference Grant, named after Wiradjuri yinaa (woman) and trailblazing pharmacist Professor Faye McMillan AM FPS.

Professor Faye McMillan is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country. She is a 2023/24 Harkness Fellow and a founding member of Indigenous Allied Health Australia, and has received numerous accolades for her leadership and contribution to population health, education, equity and the community. These include PSA Pharmacist of the Year (2022), NSW Aboriginal Woman of the Year (2019), and recognition as a Member of the Order of Australia (AM) for her work in Aboriginal and Torres Strait Islander mental health care and tertiary education.

Faye is a strong advocate for improving Indigenous health care across professions and is driven to help promote the participation and inclusion of Aboriginal and Torres Strait Islander people within pharmacy.

PSA Chief Executive Officer Adjunct Associate Professor Steve Morris says that the Grant is just one way that PSA is promoting pathways for First Nations pharmacists.

“While Aboriginal and Torres Strait Islander peoples comprise 3.8% of Australia’s total population, the current proportion of registered pharmacists who identify as Aboriginal and/or Torres Strait Islander people is much lower at just 0.3%.

“As part of our commitment to supporting and helping increase the representation of Aboriginal and Torres Strait Islander people in pharmacy, this grant opportunity looks to supporting the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.

“PSA continues to proudly support Australia’s First Nations pharmacists, and foster new pathways for the First Nations pharmacists of the future,” Adj. A/Prof Morris says.

Care Pharmaceuticals and Hydralyte Marketing Manager Joan Isaac says that support for First Nations pharmacists is key.

“Care Pharmaceuticals and Hydralyte are excited to partner with PSA for the PSA Faye McMillan Conference Grant. Recognising the significance of inclusivity, we acknowledge the ongoing need to increase participation of Aboriginal and Torres Strait Islander people in pharmacy.

“We hope this grant opportunity represents a genuine commitment to support the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.”​

Expressions of interest for the PSA Faye McMillan Conference Grant are open now. Visit https://www.psa24.com.au/grants for more information.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au